276 related articles for article (PubMed ID: 35297283)
1. Proteolysis-targeting chimera molecules targeting SHP2.
Yu D; Zheng M; Liu Y; Chen L; Li H
Future Med Chem; 2022 Apr; 14(8):587-600. PubMed ID: 35297283
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
[TBL] [Abstract][Full Text] [Related]
3. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
4. Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.
Song Y; Wang S; Zhao M; Yang X; Yu B
J Med Chem; 2022 Feb; 65(4):3066-3079. PubMed ID: 35157464
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity.
Miao J; Bai Y; Miao Y; Qu Z; Dong J; Zhang RY; Aggarwal D; Jassim BA; Nguyen Q; Zhang ZY
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836790
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in PROTACs for Drug Targeted Protein Research.
Yao T; Xiao H; Wang H; Xu X
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142231
[TBL] [Abstract][Full Text] [Related]
7. Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders.
Yang X; Wang Z; Pei Y; Song N; Xu L; Feng B; Wang H; Luo X; Hu X; Qiu X; Feng H; Yang Y; Zhou Y; Li J; Zhou B
Eur J Med Chem; 2021 Jun; 218():113341. PubMed ID: 33780898
[TBL] [Abstract][Full Text] [Related]
8. [Advances in the preclinical and clinical research of proteolysis targeting chimera].
Liu Z; Liu S
Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3615-3627. PubMed ID: 37805842
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule PROTACs: novel agents for cancer therapy.
Wan Y; Yan C; Gao H; Liu T
Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707
[TBL] [Abstract][Full Text] [Related]
10. Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3.
Shih PC; Naganuma M; Tsuji G; Demizu Y; Naito M
Bioorg Med Chem; 2023 Nov; 95():117507. PubMed ID: 37922656
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future.
Li R; Liu M; Yang Z; Li J; Gao Y; Tan R
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557960
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Small Molecule PROTACs for the Treatment of Cancer.
Li W; Elhassan RM; Hou X; Fang H
Curr Med Chem; 2021; 28(24):4893-4909. PubMed ID: 33208057
[TBL] [Abstract][Full Text] [Related]
13. Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance.
Zhu H; Wang J; Zhang Q; Pan X; Zhang J
Pharmacol Ther; 2023 Apr; 244():108371. PubMed ID: 36871783
[TBL] [Abstract][Full Text] [Related]
14. Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials.
Song Y; Zhao M; Zhang H; Yu B
Pharmacol Ther; 2022 Feb; 230():107966. PubMed ID: 34403682
[TBL] [Abstract][Full Text] [Related]
15. Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders.
Tang K; Jia YN; Yu B; Liu HM
Eur J Med Chem; 2020 Oct; 204():112657. PubMed ID: 32738411
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-activatable PROTACs for precise protein degradation and cancer therapy.
Gao J; Yang L; Lei S; Zhou F; Nie H; Peng B; Xu T; Chen X; Yang X; Sheng C; Rao Y; Pu K; Jin J; Xu Z; Yu H
Sci Bull (Beijing); 2023 May; 68(10):1069-1085. PubMed ID: 37169612
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.
Li X; Song Y
J Hematol Oncol; 2020 May; 13(1):50. PubMed ID: 32404196
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery.
Song Y; Yang X; Wang S; Zhao M; Yu B
Med Res Rev; 2022 Sep; 42(5):1781-1821. PubMed ID: 35575058
[TBL] [Abstract][Full Text] [Related]
19. PROTACs in Treatment of Cancer: A Review.
Arora P; Singh M; Singh V; Bhatia S; Arora S
Mini Rev Med Chem; 2021; 21(16):2347-2360. PubMed ID: 33634757
[TBL] [Abstract][Full Text] [Related]
20. Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation.
Miao J; Zhang ZY
ChemMedChem; 2024 Apr; 19(7):e202300669. PubMed ID: 38233347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
